Point72 Middle East Fze Abbott Laboratories Put Options Transaction History

Point72 Middle East Fze

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $2.83 Million - $3.47 Million	-31,400 Reduced 69.93%	13,500 $1.49 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $3.34 Million - $4.01 Million	35,000 Added 353.54%	44,900 $4.35 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $2.39 Million - $2.66 Million	-23,700 Reduced 70.54%	9,900 $1.08 Million
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $2.13 Million - $2.51 Million	22,000 Added 189.66%	33,600 $3.4 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $1.1 Million - $1.29 Million	11,600 New	11,600 $0

3,161

1.33B

8.63M

7.19M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $199B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Point72 Middle East Fze, based on Form 13F filings with the SEC.

Stay updated on Point72 Middle East Fze with notifications on news.